It is well established that CRP concentrations increase in response to tissue injury or inflammation and hs-CRP has been endorsed by multiple guidelines as a biomarker of atherosclerotic/cardiovascular disease risk [43,51]. Here, CRP is linked to cardiovascular disorder.